Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Aug 14, 2025

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has...

Health Ministry organizes webinar for medical officers of PHCs, district hospitals

Jun 08, 2023

The Union Ministry of Health and Family Welfare on Thursday organized a webinar on Non-Alcoholic Fatty Liver Diseases (NAFLD) to empower medical officers of...

Centre launches operational guidelines for critical illnesses including cancer, diabetes

Feb 22, 2021

New Delhi [India], February 22 : Union Minister of Health and Family Welfare Dr Harsh Vardhan launched the operational guidelines for Integration of NAFLD...

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

Mar 12, 2025

Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee...

Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg, a Critical Treatment for Chronic Liver Diseases in India

Nov 03, 2023

Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited...